<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>994</ReferenceId>
        <DateLastUpdated>2016-11-03-07:00</DateLastUpdated>
        <Article>
            <PubmedId>2586628</PubmedId>
            <Abstract>Cytotoxic T lymphocytes (CTL) constitute an essential part of the immune response against viral infections. Such CTL recognize peptides derived from viral proteins together with major histocompatibility complex (MHC) class I molecules on the surface of infected cells, and usually require in vivo priming with infectious virus. Here we report that synthetic viral peptides covalently linked to tripalmitoyl-S-glycerylcysteinyl-seryl-serine (P3CSS) can efficiently prime influenza-virus-specific CTL in vivo. These lipopeptides are able to induce the same high-affinity CTL as does the infectious virus. Our data are not only relevant to vaccine development, but also have a bearing on basic immune processes leading to the transition of virgin T cells to activated effector cells in vivo, and to antigen presentation by MHC class I molecules.</Abstract>
            <ArticleYear>1989</ArticleYear>
            <ArticlePages>561-4</ArticlePages>
            <ArticleTitle>In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Deres</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Schild</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Wiesm체ller</LastName>
                    <ForeName>K H</ForeName>
                </Author>
                <Author>
                    <LastName>Jung</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Rammensee</LastName>
                    <ForeName>H G</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institut f체r Organische Chemie, Universit채t T체bingen.</Affiliations>
            <ArticleChemicalList>H-2 Antigens;Lipoproteins;Peptide Fragments;Vaccines;Vaccines, Synthetic;Viral Proteins;Viral Vaccines;N-palmitoyl-5,6-dipalmitoyl-S-glycerylcysteinyl-seryl-serine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigen-Presenting Cells(immunology); Cytotoxicity, Immunologic; H-2 Antigens(immunology); Lipoproteins(immunology); Mice; Molecular Sequence Data; Peptide Fragments(immunology); T-Lymphocytes, Cytotoxic(immunology); Vaccines(immunology); Vaccines, Synthetic(immunology); Viral Proteins(genetics; immunology); Viral Vaccines(immunology)</ArticleMeshHeadingsList>
            <Comments>2586621  Nature. 1989 Nov 30;342(6249):478-9</Comments>
            <Journal>
                <Volume>342</Volume>
                <Issue>6249</Issue>
                <Title>Nature</Title>
                <Issn>1476-4687</Issn>
                <MedlineTa>Nature</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>NP 147-158</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>TYQRTRALVTG</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>TYQRTRALVRTG</LinearSequence>
                            <StartingPosition>147</StartingPosition>
                            <EndingPosition>158</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>11320</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>67440</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This sequence is analogous to amino acids 147-158 of the Nucleoprotein of Influenza a virus strain A PR/8/34, except that the Arginine at position 156 has been deleted.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>12305</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TYQRTRALVTG</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NP 147-158</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Fatty acid conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TYQRTRALVTG</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The animals were immunized with the epitope conjugated to tripalmitoyl-S-glycerylcysteinyl-seryl-serine (Braun's lipoprotein). In vitro stimulation was performed with the epitope or with influenza virus. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP 147-158</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>TYQRTRALVTG</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Similar responses were observed when in vitro stimulation was performed with peptide and targets were infected with Influenza A virus strain A/PR/8/34 and also when in vitro stimulation was performed with virus and targets infected with Influenza A virus strain A/PR/8/34. Negative responses were seen in spleen cells of animals immunized with peptide alone and subsequently assayed in this manner. Mice immunized with Influenza virus responded well.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP 365-380</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IASNENMETMESSTLE</LinearSequence>
                        <StartingPosition>365</StartingPosition>
                        <EndingPosition>380</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31609.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>25439</EpitopeId>
                <ReferenceStartingPosition>365</ReferenceStartingPosition>
                <ReferenceEndingPosition>380</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>12322</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000220</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IASNENMETMESSTLE</LinearSequence>
                                            <StartingPosition>365</StartingPosition>
                                            <EndingPosition>380</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P31609.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>NP 365-380</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Fatty acid conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IASNENMETMESSTLE</LinearSequence>
                                            <StartingPosition>365</StartingPosition>
                                            <EndingPosition>380</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P31609.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The animals were immunized with the epitope conjugated to tripalmitoyl-S-glycerylcysteinyl-seryl-serine (Braun's lipoprotein). In vitro stimulation was performed with the epitope or with influenza virus. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>EL-4 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>167</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>NP 365-380</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IASNENMETMESSTLE</LinearSequence>
                                        <StartingPosition>365</StartingPosition>
                                        <EndingPosition>380</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P31609.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Similar responses were observed when targets were infected with Influenza A virus strain A/PR/8/34.  It was also shown that only tripalmitoyl-S-glycerylcysteinyl-seryl-serine covalently linked to the epitope was efficient for priming.  The epitope alone, or the epitope conjugated to two Serine residues on the amino terminal were not efficient for priming.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

